Cas No. 1809323-20-3, 2-(5-bromopyridin-2-y)-2,2-difluoro-1-morpholinoethanone

Oteseconazole offers a transformative approach to prevent recurrent vulvovaginal candidiasis infections. With its broad spectrum of activity and favorable safety profile compared to previous-generation azole antifungals, Oteseconazole has the potential to revolutionize antifungal therapy. Trust our reliable intermediates to streamline your manufacturing process, ensuring a consistent supply of this essential medication. Join us in revolutionizing fungal infection management, improving patient outcomes and battling antimicrobial resistance. Embrace Oteseconazole and contribute to the future of antifungal therapeutics.